All Posts: cancer
-
Music to Our Ears: Georgetown Lombardi’s Arts & Humanities Program Receives National Endowment for the Arts Grant
(February 14, 2021) — In February, the Georgetown Lombardi Arts & Humanities Program (AHP) was awarded a grant from the National Endowment for the Arts (NEA) to study the effect of music on ICU patients’ neurologic and physiologic responses. The award appears to be the first time GUMC has received research funding from the NEA. […]
Category: Lombardi Stories
-
Mechanism for How Pancreatic Cancer Evades Immunotherapy Elucidated
Discovery could lead to new or improved therapeutic options. WASHINGTON (January 28, 2021) — Pancreatic cancer, one of the most lethal of all cancers, is capable of evading attacks by immune cells by changing its microenvironment so that the immune cells suppress, rather than support, an attack on the tumor, according to a study led […]
Category: News Release
-
Glynda’s Story: A Chance to Advance Treatment for Aggressive Cancer
(January 11, 2021) — Inspired by the kindness, proficiency and dedication of her health care team at Georgetown Lombardi Comprehensive Cancer Center, Glynda Brown, a 52-year-old Maryland resident, felt determined to “pay it forward” and make a positive difference for future patients by participating in a clinical trial after she was diagnosed with triple-negative breast […]
Category: Lombardi Stories
-
Georgetown Lombardi Oncologists Encourage Patients to Keep Up with Cancer Screenings
(November 20, 2020) — If you’re due for a routine cancer screening test, you should contact your doctor to find out if it can be safely deferred until the risk of COVID-19 goes down. In contrast, if you have symptoms that could be a sign of cancer, don’t delay and don’t let the pandemic discourage […]
Category: Lombardi Stories
-
Analyzing Tumors in Real Time to Detect Metastatic Cells Could Aid in Treatment
(November 12, 2020) — Identifying cells that metastasize from the primary tumor to other sites in the body, thereby expanding their lethality, has been a goal of scientists for years. If researchers knew more about what gives metastatic cells their ability to spread and grow throughout the body, there would be a better chance to […]
Category: Lombardi Stories
-
Immunotherapy Combo Halts Rare, Stage 4 Sarcoma in Teen
NUTLEY, NJ (October 14, 2020) — A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment had a “rapid and complete response” to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center […]
Category: News Release
-
FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research
(September 14, 2020) — Julie Shanholtz was having an uneventful summer in 2017 working full time with the same employer she’d had for the past 30 years when she developed an “odd cough” that quickly became severe, but no other symptoms. “I had always been very active and healthy — and didn’t smoke,” the 54-year-old […]
Category: Lombardi Stories
-
Georgetown Lombardi Patient Records Song with Cancer Can Rock
(August 14, 2020) — As an amateur musician, songwriting has been an outlet for decades for Seth Lucash, a patient of Michael B. Atkins, MD, deputy director at Georgetown Lombardi Comprehensive Cancer Center. “When I was about 16, I just started sitting at the piano and writing,” he said. “Writing was a very big release […]
Category: Lombardi Stories
-
First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight
(July 31, 2020) — In the field of breast screening, 3D imaging, or tomosynthesis mammography, has become the go-to screening modality over conventional digital mammography in recent years. But does 3D screening actually improve detection of — and survival from — life-threatening breast cancers, or does conventional mammography perform just as well at a lower […]
Category: Lombardi Stories
-
Georgetown Lombardi Launches COVID-19 Antibody Study in People with Cancer
WASHINGTON (April 29, 2020) — Georgetown Lombardi Comprehensive Cancer Center, in collaboration with MedStar Georgetown University Hospital, has begun a study to test for specific virus antibodies in people with cancer, who are vulnerable to COVID-19. The FDA, has approved (under an emergency use authorization) only a few tests produced commercially to detect antibodies against […]
Category: News Release